Mytrelle at Meeting on the Mesa
Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
Article Date
October 6, 2025
This article is featured on another website.
Go to article
July 31, 2026
What Makes a Modern CRO? Inside HiRO’s Global Growth Story
Part 1 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
July 31, 2026
What Makes a Modern CRO? Inside HiRO’s Global Growth Story
Part 1 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…